Europe
Medtronic plc, the global leader in medical technology, announced that it will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, in Rancho Palos Verdes, California.
Upon approval by the shareholders, ASIT biotech expects to raise between €9M and €12M of convertible notes to finance its focused development
Medtronic plc announced U.S. Food and Drug Administration clearance and commercial launch for the SelectSite C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing.
Polyphor and the University of Zurich receive an award from Innosuisse to accelerate the development of a new class of antibiotics inhibiting the LPS transport pathway
Biopharma companies from across Europe, Asia and North America share updates on business decisions and pipeline development.
The company’s board of directors hasn’t made a final decision to proceed with the listing.
The first project the companies aim to develop is a companion diagnostic for Vitrakvi, the only TRK inhibitor approved in the U.S. for patients with TRK fusion cancer across all solid tumors.
Orchard sees the gene therapy acquired as a potential treatment to “fundamentally change the lives of patients” who are born with this debilitating condition.
Medtronic plc, the global leader in medical technology, announced it will participate in the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019, in New York City.
In a whitepaper released, CENTOGENE provided an update on its induced pluripotent stem cells program.
PRESS RELEASES